CN104784443A - Coenzyme Q10 compound preparation - Google Patents
Coenzyme Q10 compound preparation Download PDFInfo
- Publication number
- CN104784443A CN104784443A CN201510220242.6A CN201510220242A CN104784443A CN 104784443 A CN104784443 A CN 104784443A CN 201510220242 A CN201510220242 A CN 201510220242A CN 104784443 A CN104784443 A CN 104784443A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- parts
- ubiquinone
- coenzyme
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a coenzyme Q10 compound preparation. The coenzyme Q10 compound preparation respectively comprises the following components in parts by weight: 18-24 parts of coenzyme Q10, 3-5 parts of L-carnitine, 1-2 parts of tea polyphenol, 1-2 parts of fructo-oligose, 0.5-1 part of isomalto-oligosaccharide, 0.02-0.04 part of taurine, 2-3 parts of soybean extract, 1-3 parts of Chinese yam extract, 0.8-1.5 parts of garlic extract, 0.4-0.8 part of black sesame powder, 0.1-0.4 part of auricularian, 0.03-0.06 part of se-enriched yeast, 0.001-0.004 part of trimethyl glycine, 0.002-0.005 part of magnesium amino acid chelate, 0.1-0.3 part of vitamin C, 0.04-0.08 part of vitamin E, 0.0001-0.0004 part of vitamin B1, 0.0001-0.00015 part of vitamin B2, 0.00005-0.0002 part of vitamin B6, and 0.0001-0.00025 part of vitamin B12. According to the invention, selected raw materials are scientific and reasonable in proportion; and human feeding trials prove that the coenzyme Q10 compound preparation has good effects of improving myocardial functions, protecting hearts, providing cardiac dynamics, resisting oxidization and increasing immunity.
Description
Technical field
The present invention relates to a kind of medical functional product, especially a kind of ubiquinone improving myocardial function, cardioprotection
10compound formulation.
Background technology
Current ubiquinone
10be mainly medicinal, the product as health food is also progressively increasing, but inquires about from the data base of state food pharmaceuticals administration general bureau, nearly all ubiquinone
10preparation is all with ubiquinone
10be main, add a small amount of auxiliary material and make.And the product that other raw materials not having compatibility to have related efficacy are made.
Summary of the invention
The invention provides a kind of ubiquinone
10compound formulation, can play good improvement myocardial function, cardioprotection, provides Cardiac Power, the effect of antioxidation, enhancing immunity.
The present invention realizes with following technical scheme: a kind of ubiquinone
10compound formulation, is characterized in that it is made up of the common hybrid process of the raw material of following portions by weight: ubiquinone
1018-24 part, L-carnitine 3-5 part, tea polyphenols 1-2 part, oligofructose 1-2 part, oligomeric isomaltose 0.5-1 part, taurine 0.02-0.04 part, soybean extract 2-3 part, Rhizoma Dioscoreae extract 1-3 part, Bulbus Allii extract 0.8-1.5 part, Semen Sesami Nigrum powder 0.4-0.8 part, Auricularia polycose 0.1-0.4 part, yeast rich in selenium 0.03-0.06 part, trimethyl glycine 0.001-0.004 part, magnesium amino acid chelate 0.002-0.005 part, vitamin C 0.1-0.3 part, vitamin E 0.04-0.08 part, vitamin B
10.0001-0.0004 part, vitamin B
20.0001-0.00015 part, vitamin B
60.00005-0.0002 part, vitamin B
120.0001-0.00025 part.
The present invention also discloses a kind of granule, tablet, hard capsule, soft capsule, powder, adds adjuvant obtain through corresponding technique by aforementioned base materials.
Ubiquinone
10be a kind of fat-soluble antioxidant, the nutrition of energy human activin cell and cellular energy, has functions such as improving body immunity, enhancing antioxidation, slow down aging and enhancing human activity, is medically widely used in cardiovascular system diseases.
Ubiquinone
10contribute to for cardiac muscle provides sufficient oxygen, prevention sudden heart disease, especially ubiquinone in myocardial ischemia process
10play pivotal role.
Experiment shows ubiquinone
10health of heart can be promoted widely, and the ubiquinone of proper content in human body
10required for suitable muscle function.Myocyte's extract biochemical analysis finds ubiquinone
10concentration lower than normal 20% time its cell mitochondrial complex I+II and the active degradation of complex I+III merit.Several research clearly shows the ubiquinone of 100-150mg/day
10supplement can obviously improve the situation suffering muscular dystrophy people.Arduous physical training decreases ubiquinone
10blood content, every day 60mg supplement found to improve athletic technical ability.Many overweight people have very low ubiquinone
10content, and supplement them can be made to deduct weight, this is due to ubiquinone
10effect can accelerate fat metabolism, make limbs and cerebral energy supply abundant, full of vitality.
The invention has the beneficial effects as follows: the present invention passes through ubiquinone
10, L-carnitine, tea polyphenols, oligofructose, oligomeric isomaltose, taurine, soybean extract, Rhizoma Dioscoreae extract, Bulbus Allii extract, Semen Sesami Nigrum powder, Auricularia polycose, yeast rich in selenium, trimethyl glycine, magnesium amino acid chelate, vitamin C, vitamin E, vitamin B
1, vitamin B
2, vitamin B
6, vitamin B
12reasonably combined, multiple dosage form can be prepared into and improve myocardial function, cardioprotection; there is provided Cardiac Power, the medical functional product of antioxidation, enhancing immunity, raw material is easy to get; preparation technology is relatively simple, and be applicable to large-scale industrialized production, cost also can be controlled.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described further.
Embodiment 1
A kind of ubiquinone
10compound formulation, said preparation is prepared into hard capsule, and its component and parts by weight are: ubiquinone
1020 parts, L-carnitine 5 parts, tea polyphenols 2 parts, oligofructose 1 part, oligomeric isomaltose 0.6 part, taurine 0.03 part, soybean extract 2 parts, Rhizoma Dioscoreae extract 3 parts, Bulbus Allii extract 1.3 parts, Semen Sesami Nigrum powder 0.7 part, Auricularia polycose 0.3 part, yeast rich in selenium 0.04 part, trimethyl glycine 0.002 part, magnesium amino acid chelate 0.004 part, vitamin C 0.3 part, vitamin E 0.05 part, vitamin B
10.0002 part, vitamin B
20.00012 part, vitamin B
60.0001 part, vitamin B
120.00013 part.By above-mentioned raw materials mix homogeneously, be filled in capsule shells by hard capsule automatic filling equipment, make hard capsule.
According to Example formulations, 1000 people try out, and wherein 933 people think that the present invention is improving myocardial function, cardioprotection, and provide Cardiac Power aspect to have significant effect, satisfaction rate is up to 93.3%.
Embodiment 2
A kind of ubiquinone
10compound formulation, said preparation is prepared into granule, and its component and parts by weight are: ubiquinone
1023 parts, L-carnitine 3 parts, tea polyphenols 1 part, oligofructose 1.5 parts, oligomeric isomaltose 0.6 part, taurine 0.02 part, soybean extract 2.2 parts, Rhizoma Dioscoreae extract 2 parts, Bulbus Allii extract 0.8 part, Semen Sesami Nigrum powder 0.4 part, Auricularia polycose 0.1 part, yeast rich in selenium 0.05 part, trimethyl glycine 0.003 part, magnesium amino acid chelate 0.002 part, vitamin C 0.1 part, vitamin E 0.06 part, vitamin B
10.00015 part, vitamin B
20.00014 part, vitamin B
60.00008 part, vitamin B
120.00018 part.Above-mentioned raw materials is added a certain amount of carboxymethyl starch sodium, after granulation, through Small bag packaging machine packaging, obtains granule product.
According to Example formulations, 1000 people try out, and wherein 947 people think that the present invention is improving myocardial function, cardioprotection, and provide Cardiac Power aspect to have significant effect, satisfaction rate is up to 94.7%.
Above to invention has been detailed introduction, the explanation of above embodiment just understands the present invention for helping.Those of ordinary skill in the art should be appreciated that to change technical scheme of the present invention, retouch or be equal to and replaces, and does not depart from the spirit and scope of technical solution of the present invention, and it all should belong in the middle of claims of the present invention.
Claims (2)
1. a ubiquinone
10compound formulation, is characterized in that it is made up of the common hybrid process of the raw material of following portions by weight: ubiquinone
1018-24 part, L-carnitine 3-5 part, tea polyphenols 1-2 part, oligofructose 1-2 part, oligomeric isomaltose 0.5-1 part, taurine 0.02-0.04 part, soybean extract 2-3 part, Rhizoma Dioscoreae extract 1-3 part, Bulbus Allii extract 0.8-1.5 part, Semen Sesami Nigrum powder 0.4-0.8 part, Auricularia polycose 0.1-0.4 part, yeast rich in selenium 0.03-0.06 part, trimethyl glycine 0.001-0.004 part, magnesium amino acid chelate 0.002-0.005 part, vitamin C 0.1-0.3 part, vitamin E 0.04-0.08 part, vitamin B
10.0001-0.0004 part, vitamin B
20.0001-0.00015 part, vitamin B
60.00005-0.0002 part, vitamin B
120.0001-0.00025 part.
2. a ubiquinone
10compound formulation, is characterized in that, the raw material of claim 1 adds adjuvant through obtained granule, tablet, hard capsule, soft capsule, the powder of corresponding technique.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510220242.6A CN104784443A (en) | 2015-05-04 | 2015-05-04 | Coenzyme Q10 compound preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510220242.6A CN104784443A (en) | 2015-05-04 | 2015-05-04 | Coenzyme Q10 compound preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104784443A true CN104784443A (en) | 2015-07-22 |
Family
ID=53549937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510220242.6A Pending CN104784443A (en) | 2015-05-04 | 2015-05-04 | Coenzyme Q10 compound preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104784443A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105795302A (en) * | 2016-04-14 | 2016-07-27 | 刘英传 | Solid conditioning health-care beverage |
| CN107048356A (en) * | 2016-03-17 | 2017-08-18 | 广东润和生物科技有限公司 | One group of ubiquinone suitable for cardiac rehabilitation phase crowd's cardioprotection10Nutrition companion's composition |
| CN108379446A (en) * | 2018-03-30 | 2018-08-10 | 上海金城药业有限公司 | Co-enzyme Q 10 formulations and preparation method thereof with auxiliary treatment male's teen bra |
| CN109043129A (en) * | 2018-07-12 | 2018-12-21 | 深圳市红瑞生物科技有限公司 | Enhance the prescription cream and preparation method thereof of pet heart function |
-
2015
- 2015-05-04 CN CN201510220242.6A patent/CN104784443A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107048356A (en) * | 2016-03-17 | 2017-08-18 | 广东润和生物科技有限公司 | One group of ubiquinone suitable for cardiac rehabilitation phase crowd's cardioprotection10Nutrition companion's composition |
| CN105795302A (en) * | 2016-04-14 | 2016-07-27 | 刘英传 | Solid conditioning health-care beverage |
| CN108379446A (en) * | 2018-03-30 | 2018-08-10 | 上海金城药业有限公司 | Co-enzyme Q 10 formulations and preparation method thereof with auxiliary treatment male's teen bra |
| CN108379446B (en) * | 2018-03-30 | 2021-05-04 | 上海金城素智药业有限公司 | Coenzyme Q10 preparation for adjuvant treatment of male oligospermia and preparation method thereof |
| CN109043129A (en) * | 2018-07-12 | 2018-12-21 | 深圳市红瑞生物科技有限公司 | Enhance the prescription cream and preparation method thereof of pet heart function |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104784443A (en) | Coenzyme Q10 compound preparation | |
| US6471969B1 (en) | Two-phase preparation | |
| TWI721248B (en) | Anti-fatigue composition used for increasing endurance performance | |
| CN104770738A (en) | Sheep placenta freeze-dried powder compound preparation | |
| KR101054594B1 (en) | Liver Function Enhancer Composition | |
| CN103120312A (en) | Composite antioxidation nutritious food and preparation method thereof | |
| EP2891496B1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING COMPLEX EXTRACT OF CRATAEGI FRUCTUS and CITRI PERICARPIUM AS AN ACTIVE INGREDIENT FOR TREATING OR PREVENTING OBESITY OR LIPID-RELATED METABOLIC DISEASES | |
| CN102150838A (en) | Weight losing composition, preparation containing same and preparation method thereof | |
| CN101185706B (en) | Hippophae rhamnoides nutrition mixture with delaying senility function and preparation technique thereof | |
| CN102940011A (en) | Biscuit containing olive extractive | |
| CN102018068A (en) | Anti-fatigue tea and preparation method thereof | |
| CN101982115A (en) | Composite for preventing and curing diabetes chronic sugar poisoning | |
| KR20160061813A (en) | A composition comprising the complex extract for enhancing power of exercise performance and promoting physical stamina | |
| CN101878913A (en) | Seabuckthorn essential oil health care products and preparation method thereof | |
| CN103110115A (en) | Composite collagen nutritional food and processing method thereof | |
| RU2670612C9 (en) | Composition for preventing or treating obesity containing a-lipoic acid and n-acetylcysteine as active ingredients | |
| WO2007077995A1 (en) | Muscle-building agent | |
| CN101991557B (en) | Liquid vancomycin hydrochloride capsule and preparation method thereof | |
| JP2022145392A (en) | Oral composition, muscle-building composition, and anti-obesity composition | |
| CN103110111A (en) | Composite anti-oxidation nutritional food and processing method thereof | |
| JP7117763B2 (en) | oral composition | |
| CN104939260A (en) | d-ribose-containing solid beverage and preparation method thereof | |
| CN104855953A (en) | Complex nutriment of tribulus terrestris extract, glutamine, taurine, various trace elements and vitamins | |
| CN102318832A (en) | Nutrition agent for improving body anti-anoxia capability | |
| CN102726643A (en) | Formula of propolis, grape pip and folium ginkgo compound preparation with function of reducing blood fat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150722 |
|
| WD01 | Invention patent application deemed withdrawn after publication |